Bellicum Pharmaceuticals Inc (BLCM)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3730 KIRBY DRIVE HOUSTON, TX 77098

Bellicum is a clinical stage biopharmaceutical company striving to deliver cures through controllable cell therapies. The company's next-generation product candidates are differentiated by powerful cell signaling technologies designed to produce more effective CAR-T cell therapies. Bellicum's GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory mechanisms.

Data as of 2021-09-19 12:57:17 -0400
Market Cap26.453 Million Shares Outstanding8.398 Million Avg 30-day Volume834.812 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.1 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.95424 52-week High/Low8.15 / 2.57 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) -12.4865
Data provided by IEX Cloud
View SEC Filings from BLCM instead.

View recent insider trading info

Funds Holding BLCM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BLCM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FAIR RICHARD A. PRESIDENT AND CEO

  • Officer
  • Director
265,000 2021-08-16 3

DALY JAMES M

  • Director
809 2021-07-01 3

KLIMOVSKY JUDITH V

  • Director
566 2021-07-01 3

DAVIS STEPHEN

  • Director
6,500 2021-06-15 2

STONEHOUSE JON P

  • Director
6,500 2021-06-15 2

HUBER REID M

  • Director
6,500 2021-06-15 2

BROWN JAMES F

  • Director
6,500 2021-06-15 2

GRASS CHARLES S. PRINCIPAL ACCOUNTING OFFICER

  • Officer
0 2021-05-11 1

STRAUSS DAVID ERIC SR DIRECTOR, CORP CONTROLLER

  • Officer
0 2020-12-15 1

WARD SHANE SR VP AND CHIEF LEGAL SO

  • Officer
1,879 2020-05-29 0

MOKARI ATABAK CHIEF FINANCIAL OFFICER

  • Officer
0 2020-04-08 0

SMITH ALAN K. EVP, TECHNICAL OPERATIONS

  • Officer
0 2020-04-08 0

FOSTER AARON E. SR VP, HEAD OF RESEARCH

  • Officer
0 2020-04-08 0

WILLIAMS ROSEMARY Y. VP, FINANCE & PAO

  • Officer
5,756 2020-01-02 0

WOODARD JR JOSEPH PAUL SVP CLINICAL & MEDICAL AFFAIRS

  • Officer
5,467 2019-11-13 0

NAEVE GREGORY S. CHIEF BUSINESS OFFICER

  • Officer
13,746 2019-08-21 0

HARRIGAN EDMUND

  • Director
0 2019-06-13 0

GROSSMAN WILLIAM SR. VP, CHIEF MEDICAL OFFICER

  • Officer
26,874 2019-02-05 0

SPENCER DAVID M. CHIEF TECHNOLOGY OFFICER

  • Officer
0 2019-02-01 0

MUSSO ALAN A CFO AND TREASURER

  • Officer
0 2018-07-02 0

MCGUYER FRANK B.

  • Director
0 2018-06-14 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
13,370,230 2018-01-17 0

MOSELEY KEN SR. VP AND GENERAL COUNSEL

  • Officer
3,658 2018-01-03 0

SLAWIN KEVIN M.

  • Director
0 2017-06-14 0

FARRELL THOMAS J. PRESIDENT AND CEO

  • Officer
  • Director
0 2017-01-03 0

MOSELEY ANNEMARIE COO/EVP CLINICAL DEVELOPMENT

  • Officer
0 2017-01-03 0

HOANG PETER L. SR. VP OF BUS. DEVELOPMENT

  • Officer
0 2017-01-03 0

SENESAC JOSEPH VP OF MANUFACTURING

  • Officer
0 2015-02-24 0

REMEDITEX VENTURES LLC

  • 10% Owner
1,807,603 2014-12-23 0

MCGUYER INVESTMENTS LTD.

  • 10% Owner
2,215,398 2014-12-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FAIR RICHARD A. - Director - Officer PRESIDENT AND CEO

2021-08-16 16:21:08 -0400 2021-08-16 A 265,000 a 265,000 direct

FAIR RICHARD A. - Director - Officer PRESIDENT AND CEO

2021-08-18 12:21:16 -0400 2021-08-16 A 265,000 a 265,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 22:15:03 UTC -3.8962 3.9662 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 21:45:03 UTC -2.8696 2.9396 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 21:15:03 UTC -2.8696 2.9396 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 20:45:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 20:15:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 19:45:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 19:15:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 18:45:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 18:15:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 17:45:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 17:15:03 UTC -2.8506 2.9206 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 16:45:03 UTC -3.9014 3.9714 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 16:15:03 UTC -3.9014 3.9714 100000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 15:45:03 UTC -3.9014 3.9714 90000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 15:15:04 UTC -3.9014 3.9714 90000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 14:45:02 UTC -3.9014 3.9714 90000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 14:15:02 UTC -3.9014 3.9714 80000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 13:45:02 UTC -3.9014 3.9714 80000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 13:15:03 UTC -3.9014 3.9714 80000
BELLICUM PHARMACEUTICALS INC BLCM 2021-09-24 12:45:03 UTC -3.9014 3.9714 80000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BLCM -2570.0 shares, $-8481.0 2021-06-30 N-PORT

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.81% 2020-02-14 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.46% 2020-03-24 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.5% 2020-02-07 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.64% 2020-03-19 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.79% 2020-03-13 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 0.99% 2020-04-09 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.39% 2020-03-25 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 0.89% 2020-04-29 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 0.59% 2020-05-22 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 0.79% 2020-05-12 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.96% 2020-03-11 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.73% 2020-02-13 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.26% 2020-03-30 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 0.69% 2020-05-18 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 0.49% 2020-06-02 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.19% 2020-04-01 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.09% 2020-04-06 GERMANY
Squarepoint Ops LLC Bellicum Pharmaceuticals Inc 1.6% 2020-02-11 GERMANY

Elevate your investments